Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway - Wikidata - wikimedia - TriplyDB

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway

http://www.wikidata.org/entity/Q33897803

about

Structural Insights into High Density Lipoprotein: Old Models and New Facts 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein HDL-apoA-I exchange: rapid detection and association with atherosclerosis Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.Protein modification by adenine propenal Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.An experimentally robust model of monomeric apolipoprotein A-I created from a chimera of two X-ray structures and molecular dynamics simulations Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathways Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.PON-dering differences in HDL function in coronary artery disease.ApoA-1 in diabetes: damaged goods.Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.Protein carbamylation renders high-density lipoprotein dysfunctional.Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers.Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.Scavenger receptor class B, type I: a promising immunotherapy target.Protein modification by aldehydophospholipids and its functional consequences.Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice.High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.The effects of caloric restriction against ethanol-induced oxidative and nitrosative cardiotoxicity and plasma lipids in rats.High Density Lipoprotein: Assembly, Structure, Cargo, and Functions

P2860

Q26770434-C971C117-98CA-40D4-8CB0-A721F31C511C Q26782039-C8AE237C-A62E-4F97-B74E-8E7D5749298C Q26996600-936B0281-F27D-4C38-B531-380DCB855B40 Q28083619-BDEFDD49-E337-4834-8479-ADDC51C47C9B Q28535779-4F07B4F1-9720-491D-8A26-A8EC551F86B3 Q30431517-8C7A34CC-B052-4090-AC43-E19B853EF3AE Q33412152-B3DDE5E3-562F-44BE-9B52-ACACB60816DC Q34372425-7F37500D-2C56-4B0B-99E9-023468D3876E Q34509546-02046269-4F18-4E40-8544-FE2213E929E1 Q34680298-D825CC9D-DFD8-4D96-9337-0AFE78545815 Q34981709-186C55C3-FD2A-473B-A2FF-F330F1F06FE0 Q35572369-B7742A97-99E8-42EA-BF9B-8038D4B3E120 Q35572457-68A8F258-E79A-45BC-BE42-8520D562735A Q35757158-E8EC49F6-CA54-40BC-A747-29718E975E4B Q35783321-4EC39AA3-B123-4FF0-B440-F16BF32EBF31 Q35838851-8AD86091-6F21-4A48-8AB9-584F158F27DF Q35886286-CF1F9D3A-DC6E-419E-83DC-73802D51EE6C Q36020300-6C24CD83-29D9-4291-A3AA-5F2CF288B9AC Q36037988-5A57CAD2-E9E7-4E22-9605-1F841CE072BD Q36050583-742E40A9-F344-476B-BA6E-0E183A85D02A Q36197871-BDA187AC-C1B4-458B-A2A3-D80CB8D6C6A8 Q36387263-EB636FC3-FCCD-4DB3-A097-9163D3734939 Q36520295-09255D7B-605D-4B17-9444-A5C641F2686A Q37118772-8FD2CCE5-E305-4795-9C86-C944E3A3FE1C Q37430678-B9B68D5C-189F-4D58-9712-477F5355D024 Q37671683-13A4DF75-65EA-40A1-A514-137E8D238723 Q37838234-FA052A11-CEDC-43F6-9AAA-D3B82A0BE0CB Q37851971-897498FD-BA51-494A-8C57-68AED47C64FE Q37997263-578E4622-0361-41C0-83F3-E1851F1EE2B2 Q38042223-5DD1B60C-2DC9-4658-8BD0-5A96F5202252 Q39450537-DA34ABC3-33E0-407A-9907-ACC6F1ED5323 Q42430021-74974144-4EC2-4011-BE80-C3FB178FBD15 Q47385866-7D3391B7-8A39-4242-8D3F-4FE542A4036E Q53099325-DC2FF996-678A-4582-8D05-2304D89ADCC0 Q54699864-8DAEF679-3F4E-4E8E-99F8-A9B3A69EBA2A Q58991979-CF762CA5-8E41-4AE0-9AC5-E486E7EFE951

P2860

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway

http://www.wikidata.org/entity/Q33897803

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@ast

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@en

type

label

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@ast

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@en

prefLabel

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@ast

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@en

P1433

Q33897803-BDDA84CA-E3CB-4CA4-BEA5-916BF7FE5DA0

P1476

Q33897803-75272440-EB62-481A-9047-AE107FE1B99F

P2093

Q33897803-48077497-B951-424C-B05A-65FDDD4CFE61

Q33897803-81ABB79A-060C-404F-8548-2B592A31B7ED

Q33897803-82CE45A6-B737-461B-BA1D-D0D94A14CB65

Q33897803-8792560B-D217-4480-8C25-A7764B0E2740

Q33897803-897B9589-5FBB-44DC-8B1F-1EC4A104806B

Q33897803-FD9AC702-A8B3-419A-B948-76A4C931D1D4

P2860

Q33897803-043101E1-D7AA-4142-9BEC-B97FC944FCF6

Q33897803-04DBA701-C75F-4C1C-8023-1E8AB11D37D7

Q33897803-0A6E79B5-B7AB-4AB4-926D-53837D676264

Q33897803-0A6F95FF-B399-49DD-819A-EC5F99D9A43E

Q33897803-0D2E4968-E7DB-4791-B22E-7A288D1D53FB

Q33897803-13CCD2E0-82A2-409E-A388-2B3464E4D18B

Q33897803-1515399E-132E-457F-97BA-F668C215AC6A

Q33897803-1F137A06-6D76-48D4-8DCB-C7FA1BC79A5C

Q33897803-249CB4ED-9027-4C6B-B187-63FE5F5337DE

Q33897803-25314680-2D96-4771-AC54-5001D50E3CBA

P304

Q33897803-E958D309-A51B-4E6C-992F-4E43763B368B

P31

Q33897803-9C69C897-F6E9-4FA2-8CB9-9598B43BE917

P356

Q33897803-9292855F-33FF-45A0-8C71-735597711B2B

P407

Q33897803-554C5A14-0386-44B3-BDFF-0806A442F32E

P433

Q33897803-B6A21885-6DE2-4CE8-98AE-79BA4653CCEB

P478

Q33897803-FA145CB6-C17A-4EE6-B7A0-9D1E26C96AC8

P50

Q33897803-02C8F4BE-2562-4FAC-ABFD-1C35D63936FB

P577

Q33897803-188D40CB-F3A8-4C54-9200-A0DD085FB54F

P5875

Q33897803-7AD5DF26-22E1-4FDA-BEEF-08B2E8DE53AB

P698

Q33897803-8C439ED1-BDA1-4959-B713-49597BE03D0C

P932

Q33897803-175F7889-75CC-4473-807B-A0FE8C07A986

P356

JBC.M110.118182

P1433

Journal of Biological Chemistry

P1476

Modifying apolipoprotein A-I b ...... ol efflux by the ABCA1 pathway

@en

P2093

Baohai Shao

http://www.w3.org/2001/XMLSchema#string

Ioanna Pagani

http://www.w3.org/2001/XMLSchema#string

Jay W Heinecke

http://www.w3.org/2001/XMLSchema#string

John F Oram

http://www.w3.org/2001/XMLSchema#string

Michael N Oda

http://www.w3.org/2001/XMLSchema#string

Subramaniam Pennathur

http://www.w3.org/2001/XMLSchema#string

P2860

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Nonenzymatic glycosylation of human serum albumin alters its conformation and function

Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.

Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.

The importance of lipid-derived malondialdehyde in diabetes mellitus.

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

The plasma lecithins:cholesterol acyltransferase reaction.

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

P304

18473-18484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.118182

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

Joseph L Witztum

P577

2010-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43079873

http://www.w3.org/2001/XMLSchema#string

P698

20378541

http://www.w3.org/2001/XMLSchema#string

P932

2881773

http://www.w3.org/2001/XMLSchema#string